Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 3 × Unknown × Morphine × Clear all

Phase

Phase 4 3 Phase NA 2 Phase 3 2 Phase 2 2 Phase 2/3 1

Status

Completed 7 Terminated 3 Unknown 2 Recruiting 2 Withdrawn 1 Suspended 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Pain, Intractable 1 Pain 1

Interventions

Cisplatin 113 Radiotherapy 86 Paclitaxel 68 Carboplatin 68 Cyclophosphamide 67 Fluorouracil 66 Docetaxel 60 Gemcitabine 59 Capecitabine 58 Oxaliplatin 53 Etoposide 51 Doxorubicin 50 Vincristine 39 Leucovorin 38 Chemotherapy, Adjuvant 35 Cytarabine 34 Drug Therapy 29 Dexamethasone 28 Epirubicin 25 Bevacizumab 23 Pemetrexed 22 Prednisone 21 Irinotecan 21 Tamoxifen 20 Neoadjuvant Therapy 19 Rituximab 18 Radiotherapy, Intensity-Modulated 18 apatinib 17 Vinorelbine 17 Methotrexate 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02687347 2016-09-20

UDOME

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 3 Unknown

Pain, Intractable

NCT00822614 2009-01-14

FINDS

Akela Pharma, Inc.

Phase 3 Unknown

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡